Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment

Go back to Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment
(AMEX: AVAI) Delayed: 0.19 +0.01 (5.56%)
Previous Close $0.18    52 Week High
Open $0.18    52 Week Low
Day High $0.19    P/E N/A 
Day Low $0.15    EPS
Volume 83,166